Class information for: |
Basic class information |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | ONCOLOGY//CELL BIOLOGY//BIOCHEMISTRY & MOLECULAR BIOLOGY | 2934640 |
304 | 3 | DNA METHYLATION//FRAGILE X SYNDROME//RETT SYNDROME | 41307 |
384 | 2 | DNA METHYLATION//EPIGENETICS//METHYLATION | 17479 |
5958 | 1 | DECITABINE//AZACITIDINE//ZEBULARINE | 1581 |
Terms with highest relevance score |
rank | Category | termType | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|---|
1 | DECITABINE | authKW | 1788822 | 11% | 50% | 180 |
2 | AZACITIDINE | authKW | 1614431 | 10% | 53% | 153 |
3 | ZEBULARINE | authKW | 519067 | 3% | 61% | 43 |
4 | 5 AZA 2 DEOXYCYTIDINE | authKW | 512289 | 6% | 27% | 97 |
5 | HYPOMETHYLATING AGENTS | authKW | 421592 | 3% | 38% | 55 |
6 | MYELODYSPLASTIC SYNDROME | authKW | 289470 | 14% | 6% | 225 |
7 | DNA METHYLTRANSFERASE INHIBITOR | authKW | 274276 | 2% | 40% | 34 |
8 | EPIGENETIC THERAPY | authKW | 233816 | 3% | 27% | 44 |
9 | FAZARABINE | authKW | 181208 | 1% | 91% | 10 |
10 | AZACYTIDINE | authKW | 143964 | 1% | 33% | 22 |
Web of Science journal categories |
chi_square_rank | Category | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | Oncology | 15896 | 52% | 0% | 821 |
2 | Hematology | 12302 | 27% | 0% | 428 |
3 | Pharmacology & Pharmacy | 662 | 14% | 0% | 224 |
4 | Chemistry, Medicinal | 203 | 4% | 0% | 65 |
5 | Cell Biology | 199 | 8% | 0% | 123 |
6 | Genetics & Heredity | 142 | 5% | 0% | 85 |
7 | Biochemistry & Molecular Biology | 119 | 12% | 0% | 188 |
8 | Medicine, Research & Experimental | 106 | 4% | 0% | 68 |
9 | Toxicology | 16 | 2% | 0% | 28 |
10 | Cell & Tissue Engineering | 9 | 0% | 0% | 5 |
Address terms |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | RECH PEDIAT | 86466 | 1% | 27% | 16 |
2 | LEUKEMIA | 69436 | 6% | 4% | 95 |
3 | EPIGENET TARGETING CANC | 59799 | 0% | 100% | 3 |
4 | ETAC | 53152 | 0% | 67% | 4 |
5 | SECT MDS | 39866 | 0% | 100% | 2 |
6 | UNITE MEDYCSFR C SANTE | 39866 | 0% | 100% | 2 |
7 | URCA CNRS FRE 3481 | 39866 | 0% | 100% | 2 |
8 | CRDPF | 35432 | 0% | 44% | 4 |
9 | LEUKEMIA PROGRAM | 26919 | 1% | 10% | 14 |
10 | LEUKEMIA EXPT THER EUT | 26576 | 0% | 67% | 2 |
Journals |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | LEUKEMIA RESEARCH | 19245 | 5% | 1% | 77 |
2 | CLINICAL EPIGENETICS | 9373 | 1% | 3% | 15 |
3 | LEUKEMIA | 5895 | 3% | 1% | 48 |
4 | EPIGENETICS | 5413 | 1% | 2% | 15 |
5 | ANNALS OF HEMATOLOGY | 3797 | 2% | 1% | 27 |
6 | INVESTIGATIONAL NEW DRUGS | 3683 | 1% | 1% | 22 |
7 | CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 3389 | 1% | 1% | 12 |
8 | LEUKEMIA & LYMPHOMA | 3101 | 2% | 0% | 35 |
9 | EPIGENOMICS | 3034 | 1% | 2% | 9 |
10 | CLINICAL CANCER RESEARCH | 1922 | 2% | 0% | 39 |
Author Key Words |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass | LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | DECITABINE | 1788822 | 11% | 50% | 180 | Search DECITABINE | Search DECITABINE |
2 | AZACITIDINE | 1614431 | 10% | 53% | 153 | Search AZACITIDINE | Search AZACITIDINE |
3 | ZEBULARINE | 519067 | 3% | 61% | 43 | Search ZEBULARINE | Search ZEBULARINE |
4 | 5 AZA 2 DEOXYCYTIDINE | 512289 | 6% | 27% | 97 | Search 5+AZA+2+DEOXYCYTIDINE | Search 5+AZA+2+DEOXYCYTIDINE |
5 | HYPOMETHYLATING AGENTS | 421592 | 3% | 38% | 55 | Search HYPOMETHYLATING+AGENTS | Search HYPOMETHYLATING+AGENTS |
6 | MYELODYSPLASTIC SYNDROME | 289470 | 14% | 6% | 225 | Search MYELODYSPLASTIC+SYNDROME | Search MYELODYSPLASTIC+SYNDROME |
7 | DNA METHYLTRANSFERASE INHIBITOR | 274276 | 2% | 40% | 34 | Search DNA+METHYLTRANSFERASE+INHIBITOR | Search DNA+METHYLTRANSFERASE+INHIBITOR |
8 | EPIGENETIC THERAPY | 233816 | 3% | 27% | 44 | Search EPIGENETIC+THERAPY | Search EPIGENETIC+THERAPY |
9 | FAZARABINE | 181208 | 1% | 91% | 10 | Search FAZARABINE | Search FAZARABINE |
10 | AZACYTIDINE | 143964 | 1% | 33% | 22 | Search AZACYTIDINE | Search AZACYTIDINE |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Classes with closest relation at Level 1 |